Literature DB >> 1848263

Chronic intracerebroventricular infusions of endothelin elevate arterial pressure in rats.

M Nishimura1, H Takahashi, M Matsusawa, I Ikegaki, M Sakamoto, T Nakanishi, M Hirabayashi, M Yoshimura.   

Abstract

We investigated the effects of intracerebroventricular infusions of endothelin on cardiovascular and endocrinological responses using conscious, unrestrained rats. Chronic intracerebroventricular infusions of endothelin, 10 pmol/h for 7 days, elevated arterial pressure significantly on days 5, 6 and 7 of the infusion, compared with intracerebroventricular infusions of the vehicle. Heart rate decreased from day 1 of the infusion of endothelin until the end of the experiment. The urinary excretion of norepinephrine increased on day 3 and epinephrine increased on days 3, 4 and 5 of endothelin infusion. The urinary excretion of arginine vasopressin increased on day 5, 6 and 7 of the infusion. These findings suggest that chronic intracerebroventricular infusions of endothelin elicit elevations in arterial pressure and that the initiation of blood pressure rises can be related to sympathetic activation although the actual role for the pressor responses has been played by the released arginine vasopressin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848263     DOI: 10.1097/00004872-199101000-00011

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Endothelin regulation of neuropeptide release from nerve endings of the posterior pituitary.

Authors:  M F Ritz; E L Stuenkel; G Dayanithi; R Jones; J J Nordmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 3.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 4.  Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

5.  Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long-Evans rats.

Authors:  N F Rossi
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

6.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

Authors:  W G Haynes; M F Hand; H A Johnstone; P L Padfield; D J Webb
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

7.  Immunohistochemical evidence of endothelin-1 in human choroid plexus.

Authors:  M H Jiang; L Eriksson; Y Olsson
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Role of paraventricular nucleus vasopressin V1A receptors in the response to endothelin 1 activation of the subfornical organ in the rat.

Authors:  N F Rossi; M Maliszewska-Scislo
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

9.  Endothelin-1 in paraventricular nucleus modulates cardiac sympathetic afferent reflex and sympathetic activity in rats.

Authors:  Ai-Dong Chen; Xiao-Qing Xiong; Xian-Bing Gan; Feng Zhang; Ye-Bo Zhou; Xing-Ya Gao; Ying Han
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  Activation of neuronal endothelin B receptors mediates pressor response through alpha-1 adrenergic receptors.

Authors:  Bryan K Becker; Joshua S Speed; Mackenzie Powell; David M Pollock
Journal:  Physiol Rep       Date:  2017-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.